Abstract:Endocytic trafficking of many types of receptors can have profound effects on subsequent signaling events. Quantitative models of these processes, however, have usually considered trafficking and signaling independently. Here, we present an integrated model of both the trafficking and signaling pathway of the epidermal growth factor receptor (EGFR) using a probability weighted-dynamic Monte Carlo simulation. Our model consists of hundreds of distinct endocytic compartments and approximately 13,000 reactions/events that occur over a broad spatio-temporal range. By using a realistic multicompartment model, we can investigate the distribution of the receptors among cellular compartments as well as their potential signal transduction characteristics. Our new model also allows the incorporation of physiochemical aspects of ligand-receptor interactions, such as pH-dependent binding in different endosomal compartments. To determine the utility of this approach, we simulated the differential activation of the EGFR by two of its ligands, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha). Our simulations predict that when EGFR is activated with TGF-alpha, receptor activation is biased toward the cell surface whereas EGF produces a signaling bias toward the endosomal compartment. Experiments confirm these predictions from our model and simulations. Our model accurately predicts the kinetics and extent of receptor downregulation induced by either EGF or TGF-alpha. Our results suggest that receptor trafficking controls the compartmental bias of signal transduction, rather than simply modulating signal magnitude. Our model provides a new approach to evaluating the complex effect of receptor trafficking on signal transduction. Importantly, the stochastic and compartmental nature of the simulation allows these models to be directly tested by high-throughput approaches, such as quantitative image analysis.

Spreading of EGF Receptor Activity into EGF-free Regions and Molecular Therapies of Cancer

Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation

Molecular Mechanism Study of EGFR Allosteric Inhibitors Using Molecular Dynamics Simulations and Free Energy Calculations

Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics

[Tumor Biotherapy Based on Epidermal Growth Factor Receptor As a Target].

Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics

Development of Egfr Family Small Molecule Inhibitors for Anticancer Intervention: an Overview of Approved Drugs and Clinical Candidates

The EGF receptor family as targets for cancer therapy

Mechanism for Activation of Mutated Epidermal Growth Factor Receptors in Lung Cancer

The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data

Structural Basis for EGFR Transmembrane Signaling and Its Implications in Therapeutic Development

Single-molecule study of lateral mobility of epidermal growth factor receptor 2/HER2 on activation.

Spatial control of EGF receptor activation by reversible dimerization on living cells

An integrated model of epidermal growth factor receptor trafficking and signal transduction

Molecular Dynamics Analysis of Binding Sites of Epidermal Growth Factor Receptor Kinase Inhibitors

Advances in Anti-Tumor Therapy Targeting the EGFR Family of Receptor Tyrosine Kinases

Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication.

Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors

Insight into the Medicinal Chemistry of Egfr and Her-2 Inhibitors

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance

Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer